Joris Van Dam

CEO and Co-Founder at Advokare

Cambridge, Massachusetts, United States

About

Visionary leader with 20+ years experience leading innovation in digital health. Successful track record of driving initiatives from vision to execution to impact. Full Stack Product Manager fluent in digital health product strategy, AI/ML, healthcare data, real-world data and data interoperability, user experience, regulatory strategy, agile development and cross-functional leadership. Deep experience in clinical research, healthcare in the US, EU, Sub-Saharan Africa and India. Implemented clinicogenomic data platform fueling AI innovation and research in cancer diagnostics, delivering up to 80% cost reduction and 10 months acceleration in research studies. Spearheaded Digital Therapeutics initiatives in Pharma; led partnership with Pear Therapeutics. Launched TriNetX, one of the leading Real World Data companies today, and CentrosHealth (patient experience in clinical trials) - acquired by ClinicalInk. Passionate about using AI to accelerate the learning cycle in healthcare, and to make healthcare suck less for all.

Experience

  • Chief Executive Officer at Advokare
    Mar 2025 - Present · 1 yr 5 mos

    Democratizing evidence-based care with the help of AI.

  • Exact Sciences ()
    • VP Data Innovation
      Nov 2023 - Mar 2025 · 1 yr 5 mos

      Accelerate the translation of medical innovation from biomarker to bedside to public health impact with Real World Data and AI. - Launched "scientific data platform" covering > 10million patients linked to real world outcomes - supporting > 50 publications at > 80% cost savings, > 6 studies generating > $10Mio cost savings and up to 10 months study acceleration, enabling company's AI initiatives, and the company's first AI hackathon. - Drove key data innovation partnerships e.g. with Flatiron Health, Datavant, OM1 and others. - Developed cross-departmental , 50+ colleagues data innovation community (who are still going strong!)

    • VP, Clinical Trials Innovation and Strategy
      Sep 2022 - Nov 2023 · 1 yr 3 mos

      - Led the transformation of Exact Sciences clinical research through design and development of advanced clinical systems architecture and capabilities. - Drove broad adoption of tokenization and Real World Data acquisition through study portfolio - driving >10Mio cost avoidance across the portfolio - Developed network of 40+ clinical trial innovators across research functions and partner functions.

    • VP Digital Strategy
      Aug 2021 - Sep 2022 · 1 yr 2 mos

      - Developed and market-tested digital health strategy to unlock direct-to-consumer customer segment , with estimated revenue contributions of up to 20% in 5 years - Set up the Strategy and New Products team for the Customer and Digital Experience organization

  • Novartis Institutes for BioMedical Research (NIBR) (10 yrs 8 mos)
    • Executive Director, Head of Digital Therapeutics
      Mar 2018 - Jul 2021 · 3 yrs 5 mos

      - Developed and executed strategy for Digital Therapeutics. - Led strategy and implementation of Novartis' unique partnership with Pear Therapeutics for the development of novel digital therapies in the treatment of Multiple Sclerosis and Schizophrenia - Created DTX SME network across the organization - Board member of Digital Therapeutics Alliance - Published edited volume on the strategic, scientific and regulatory development of digital therapeutics

    • Director Project Management Planning, Strategic Projects Leader
      Dec 2010 - Feb 2018 · 7 yrs 3 mos

      Lead Strategic Projects to revolutionize clinical research at Novartis: - Digital Therapeutics: Lead development of Digital Therapeutics Strategy for Novartis. - Digital Capability Building, Africa: lead building of digital capabilities at research sites in developing world countries, with focus on Africa, to support their greater participation to clinical research, and earlier access to innovative medicines. - Lead development and roll out of mobile patient register in Zambia, in support of local research study to screen school children for Rheumatic Heart Disease (http://www.novartis.com/newsroom/media-releases/en/2013/1681877.shtml). - Launch new company, with venture capital partner, to use big data for improved design, planning and recruitment in clinical trials (http://trinetx.com/). - Launch new company, with venture capital partner, to facilitate and promote use of Patient Engagement Apps in clinical trials. Company acquired by ClinicalInk (http://www.clinicalink.com/march-18-2015/). - Launch “Patients2Trials Consortium”, a collaboration with Lilly and Pfizer to facilitate access to clinical research information for patients, providers and caregivers (https://www.whitehouse.gov/sites/default/files/microsites/ostp/Data2Action%20Press%20Release.pdf ). Project acquired by TrialReach (http://www.forbes.com/sites/zinamoukheiber/2015/04/23/drug-companies-pin-hopes-on-trialreach-to-enroll-patients-in-clinical-trials-faster/ ). - Launch Clinical Research Collaboration between Novartis and Walgreens (http://www.fiercecro.com/story/novartis-chief-touts-new-effort-offer-streamlined-consumer-friendly-trials/2012-03-22). - Launch Trials of the Future, Novartis’ initiative to revolutionize the conduct of clinical research studies by lowering the burden of patient and provider participation (http://www.pharmafile.com/news/180687/novartis-rd-looking-sweet-spot).

  • Johnson & Johnson (4 yrs 10 mos)
    • Director Health Information Science, Pharma R&D
      Jan 2008 - Nov 2010 · 2 yrs 11 mos

      Development and delivery of project portfolio to research the use of health information solutions for improved access, affordability, safety and quality of care in various diseases areas and geographic regions - including - Development and execution of business opportunity plan for creation of new venture for the development of HealthCare Information solutions. - Startup of the UNITE consortium, unique partnership between Janssen, the Bill and Melinda Gates Foundation, the Grameen Foundation, the Indian Institute of Technology, the Johns Hopkins Center for Clinical Global Health Education, and ten Aids clinics across India to improve outcomes (reduce treatment failure) of first line HIV treatment by use of comprehensive patient support solution delivered through cell phone. Led observational / design study, developed platform requirements, started up platform development. - Represent Janssen in set up of EHR4CR project (http://www.ehr4cr.eu/), a 5 year, EUR 16 Mio public-private-partnership between 10 pharmaceutical companies and 24 public partners to accelerate clinical research by the reuse of electronic health record data. - Led development of public-private-partnership with EHR systems vendor and with academic medical centers in Germany to develop an open platform for the reuse of EHR data to improve clinical care.

    • Director IT - Global Clinical Operations (GCO)
      Feb 2006 - Dec 2009 · 3 yrs 11 mos

      Responsible for delivery of global IT services to clinical study management teams - clinical study management system, electronic trial master file, contractor study managers, ...

  • Senior Manager Technology at Accenture
    Dec 2003 - Feb 2006 · 2 yrs 3 mos

    IT strategy Project and Program Management ITIL, CMM, eSCM Outsourcing Data Center consolidation